Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-05

Study Completion Date

2021-05-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess whether the 1 minute Sit to Stand (STS) test can be used as a measure of submaximal endurance during a pulmonary exacerbation of Cystic Fibrosis (CF) for patients in the acute care setting. We hypothesize that if the STS test is a valid measure of submaximal cardiovascular endurance, it will moderately correlate with 6 minute walk distance (6MWD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Sit-to-stand Test in Patients With Cystic Fibrosis and Matched Controls.

NCT03524859

Cystic Fibrosis

COMPLETED

Sit-to-stand Test in Cystic Fibrosis Children and Adolescents

NCT03069625

Cystic Fibrosis

COMPLETED NA

1STST and Muscle Weakness in CF Patients

NCT03117764

Cystic Fibrosis

COMPLETED NA

Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.

NCT01848392

Cystic Fibrosis

COMPLETED

Effects of a Partially Supervised Conditioning Program in CF

NCT01744561

Cystic Fibrosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cystic Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

6MWT and STS

All participates will receive 6MWT and STS test

Group Type EXPERIMENTAL

Sit to stand test

Intervention Type DIAGNOSTIC_TEST

Participants will complete a sit to stand test in addition to a 6 minute walk test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sit to stand test

Participants will complete a sit to stand test in addition to a 6 minute walk test

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

6 minute walk test

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients age 6-35 with cystic fibrosis who are admitted for a pulmonary exacerbation and receive ongoing physical therapy throughout their admission.

Exclusion Criteria

* patients with cystic fibrosis who are under the age of 6,
* patients with cystic fibrosis who are not admitted for a pulmonary exacerbation,
* patients with cystic fibrosis who are not being followed regularly by physical therapy (\>5x/week) throughout their inpatient admission,
* patients with cystic fibrosis who are unable to follow instructions for standardized testing,
* patients with cystic fibrosis who are not medically stable to participate in submaximal exercise testing.
* patients whose inpatient admission is anticipated to be \<1 week.
* Patients who are readmitted to the hospital within the year will not be included in the study more than once.

Minimum Eligible Age

6 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No